Natco Pharma tumbles after Delhi HC allows injuction application by FMC Corp business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.
Natco Pharma rose 2.30% to Rs 920.45 after the company said it received approval for chlorantraniliprole (CTPR)-1st key product of crop health sciences division.
In a BSE filing made during market hours today, the company announced the approval of registration by the Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of chlorantraniliprole (CTPR) Technical. NATCO would be the 1st indigenous manufacturer of this technical product, the company said in the filing.
CTPR technical is formulated into broad-spectrum insecticides used in several crops for better pest management. The active ingredient is used across products commercialised by FMC under its brands Coragen and Ferterra.
Natco Pharma Ltd: Natco Pharma gets registration approval from CIB&RC for Chlorantraniliprole indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
CTPR is an active ingredient used in products commercialised by US-based chemicals maker FMC under brands Coragen and Ferterra., , natco pharma, Chlorantraniliprole, manufacturer, technical product